Zhitong Finance App News, Lisheng Pharmaceutical (002393.SZ) announced that the company's subsidiary, Tianjin Central Pharmaceutical Co., Ltd. (“Central Pharmaceutical”), has received the “Drug Registration Certificate” issued by the State Drug Administration for 10 mg specifications; the “Drug Registration Certificate” for apomistel tablets 20 mg; and the “Drug Registration Certificate” for apomistel tablets 30 mg. The above drugs have passed the drug marketing license application.

Zhitong Finance App News, Lisheng Pharmaceutical (002393.SZ) announced that the company's subsidiary, Tianjin Central Pharmaceutical Co., Ltd. (“Central Pharmaceutical”), has received the “Drug Registration Certificate” issued by the State Drug Administration for 10 mg specifications; the “Drug Registration Certificate” for apomistel tablets 20 mg; and the “Drug Registration Certificate” for apomistel tablets 30 mg. The above drugs have passed the drug marketing license application.